SBRT Increases PFS in Advanced NSCLC
![Trevor Feinstein, MD](/client_files/image/news/feinstein-news-lg.jpg)
Stereotactic Body Radiotherapy (SBRT) Increases Progression Free Survival (PFS) in advanced Metastatic Non-Small Cell Lung Cancer (NSCLC), Study Suggests. Trevor Feinstein, MD praises the study and suggests a closer look at the characteristics of those who responded.